Published 20:15 IST, October 16th 2020
WHO backs remdesivir trial data after Gilead terms it inconsistent with 'robust evidence'
WHO trial data on Gilead Sciences Inc.'s remdesivir is reliable, said an independent statistician hired by the UN health agency to evaluate the results.
null | Image:
self
Advertisement
Loading...
20:15 IST, October 16th 2020